Absence of effect of SLC22A2 genotype on cisplatin-induced nephrotoxicity in oesophageal cancer patients receiving cisplatin and 5-fluorouracil: report of results discordant with those of earlier studies.

Hinai, Y

Absence of effect of SLC22A2 genotype on cisplatin-induced nephrotoxicity in oesophageal cancer patients receiving cisplatin and 5-fluorouracil: report of results discordant with those of earlier studies. [electronic resource] - Journal of clinical pharmacy and therapeutics Dec 2013 - 498-503 p. digital

Publication Type: Journal Article

1365-2710

10.1111/jcpt.12097 doi


Aged
Aged, 80 and over
Analysis of Variance
Antineoplastic Agents--adverse effects
Blood Cell Count
Chemoradiotherapy
Cisplatin--adverse effects
DNA--genetics
Electrolytes--blood
Esophageal Neoplasms--drug therapy
Female
Fluorouracil--therapeutic use
Genotype
Glomerular Filtration Rate
Humans
Kidney Diseases--chemically induced
Kidney Function Tests
Male
Middle Aged
Organic Cation Transport Proteins--genetics
Organic Cation Transporter 2
Regression Analysis